RXD vs. JDOC

Last updated Jul 17, 2026

RXD (ProShares UltraShort Health Care) and JDOC (Jpmorgan Healthcare Leaders ETF) are both exchange-traded funds - RXD is a Leveraged Equities fund tracking the DJ Global United States (All) / Health Care -IND (-200%), while JDOC is a Health & Biotech Equities fund actively managed by JPMorgan. RXD is passively managed, while JDOC is actively managed. Over the past year, RXD returned -31.61% vs 21.61% for JDOC. At a correlation of -0.90, they often move in opposite directions. RXD charges 0.95%/yr vs 0.65%/yr for JDOC.

Performance

RXD vs. JDOC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraShort Health Care (RXD) and Jpmorgan Healthcare Leaders ETF (JDOC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RXD achieves a -9.19% return, which is significantly lower than JDOC's 4.84% return.

RXD

• 1D: -4.64%
• 1M: -12.05%
• 6M: -7.00%
• YTD: -9.19%
• 1Y: -31.61%
• 3Y*: -10.78%
• 5Y*: -8.36%
• 10Y*: -19.81%

JDOC

• 1D: 1.33%
• 1M: 6.39%
• 6M: 2.75%
• YTD: 4.84%
• 1Y: 21.61%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RXD vs. JDOC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
RXD ProShares UltraShort Health Care	-9.19%	-21.66%	4.83%	-15.53%
JDOC Jpmorgan Healthcare Leaders ETF	4.84%	15.36%	-1.04%	7.92%

Correlation

The correlation between RXD and JDOC is -0.91, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.91
Correlation (All Time) Calculated using the full available price history since Nov 2, 2023	-0.90

The correlation between RXD and JDOC has been stable across timeframes, ranging from -0.91 to -0.90 - a consistent structural relationship.

Return for Risk

RXD vs. JDOC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXD

RXD Risk / Return Rank: 2
RXD Sharpe Ratio Rank: 2
RXD Sortino Ratio Rank: 2
RXD Omega Ratio Rank: 2
RXD Calmar Ratio Rank: 2
RXD Martin Ratio Rank: 3

JDOC

JDOC Risk / Return Rank: 53
JDOC Sharpe Ratio Rank: 53
JDOC Sortino Ratio Rank: 61
JDOC Omega Ratio Rank: 50
JDOC Calmar Ratio Rank: 55
JDOC Martin Ratio Rank: 44

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RXD vs. JDOC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and Jpmorgan Healthcare Leaders ETF (JDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RXD	JDOC	Difference
Sharpe ratio: Return per unit of total volatility	-1.01	1.46	-2.47
Sortino ratio: Return per unit of downside risk	-1.33	2.32	-3.65
Omega ratio: Gain probability vs. loss probability	0.84	1.26	-0.42
Calmar ratio: Return relative to maximum drawdown	-0.82	2.24	-3.06
Martin ratio: Return relative to average drawdown	-1.29	5.67	-6.96

RXD vs. JDOC - Sharpe Ratio Comparison

The current RXD Sharpe Ratio is -1.01, which is lower than the JDOC Sharpe Ratio of 1.46. The chart below compares the historical Sharpe Ratios of RXD and JDOC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RXD vs. JDOC - Drawdown Comparison

The maximum RXD drawdown since its inception was -99.67%, which is greater than JDOC's maximum drawdown of -20.87%. Use the drawdown chart below to compare losses from any high point for RXD and JDOC.

Drawdown Indicators

	RXD	JDOC	Difference
Max Drawdown Largest peak-to-trough decline	-99.67%	-20.87%	-78.80%
Max Drawdown (1Y) Largest decline over 1 year	-38.77%	-9.68%	-29.09%
Max Drawdown (3Y) Largest decline over 3 years	-40.62%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-44.27%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-91.23%	—	—
Current Drawdown Current decline from peak	-99.66%	-2.22%	-97.44%
Average Drawdown Average peak-to-trough decline	-81.96%	-6.80%	-75.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.61%	3.82%	+20.79%

Volatility

RXD vs. JDOC - Volatility Comparison

ProShares UltraShort Health Care (RXD) has a higher volatility of 12.04% compared to Jpmorgan Healthcare Leaders ETF (JDOC) at 5.44%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than JDOC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RXD	JDOC	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.04%	5.44%	+6.60%
Volatility (6M) Calculated over the trailing 6-month period	23.68%	11.33%	+12.35%
Volatility (1Y) Calculated over the trailing 1-year period	31.49%	14.88%	+16.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.25%	14.67%	+15.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.07%	14.67%	+18.40%

RXD vs. JDOC - Expense Ratio Comparison

RXD has a 0.95% expense ratio, which is higher than JDOC's 0.65% expense ratio.

Dividends

RXD vs. JDOC - Dividend Comparison

RXD's dividend yield for the trailing twelve months is around 3.27%, more than JDOC's 0.84% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
JDOC Jpmorgan Healthcare Leaders ETF	0.84%	0.89%	5.57%	0.15%	0.00%	0.00%	0.00%	0.00%	0.00%
RXD ProShares UltraShort Health Care	3.27%	3.29%	4.36%	3.17%	0.67%	0.00%	0.17%	1.73%	0.22%

Frequently Asked Questions

Can I hold both RXD and JDOC in my portfolio?

RXD and JDOC have a correlation of -0.91, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RXD or JDOC?

RXD has higher volatility (12.04%) compared to JDOC (5.44%). In terms of maximum drawdown, RXD dropped -99.67% vs JDOC's -20.87%.

Which ETF is better, RXD or JDOC?

On 1-year performance, JDOC leads with 21.61% vs -31.61% for RXD. On fees, JDOC is cheaper at 0.65% per year. On volatility, JDOC has been the lower-risk option at 5.44%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, RXD or JDOC?

Over the 1-year period, JDOC has performed better with a 21.61% return vs -31.61%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, RXD or JDOC?

JDOC is cheaper with a 0.65% expense ratio, compared with 0.95% for RXD.

Which ETF pays a higher dividend yield, RXD or JDOC?

RXD has the higher dividend yield at 3.27%, compared with 0.84% for JDOC.

What is the main difference between RXD and JDOC?

RXD is categorized as Leveraged Equities, while JDOC is Health & Biotech Equities. They also come from different issuers: ProShares and JPMorgan. Their fees differ too: 0.95% for RXD and 0.65% for JDOC.

Which has better risk-adjusted returns?

JDOC currently has the higher Sharpe Ratio (1.46 vs -1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.